Study of NTI164 for children and young adults with autism
Part of Mental health clinical trials.
This trial tests a new medicine called NTI164 in people aged 6 to 25 with moderate to severe autism. It aims to see if the treatment can help with symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be between 6 and 25 years old.
- Diagnosis of Level II or III autism (requires moderate to severe support).
- All current treatments (medications, therapies) for autism must have been stable for the last 12 weeks.
- Must be able to swallow liquids.
- No recent or current use of cannabis or certain other medications (e.g., omeprazole, warfarin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This study tests whether an antioxidant supplement (something that fights cell damage) can help children with autism. It lasts 3 months and requires that the child stays on their current treatments without changes.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This trial tests a device called the NeuroCytotron to see if it can help people with autism. It is for individuals aged 3 to 50 who have a confirmed autism diagnosis and are medically stable.
This trial tests a new brain stimulation therapy (called NeuroCytotron) to see if it helps children with autism who have some verbal communication. The goal is to help the brain form new connections and improve symptoms.
This study tests a computerized “cognitive remediation” program adapted for people with autism, using social scenarios and skills. The goal is to improve thinking and related day-to-day abilities by practicing structured tasks on a screen.
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.